Concepedia

Dimitry Ofengeim

DO

26

Publications

4.1K

Citations

23

H-Index

2006

Active since

Affiliations

Harvard University(Current)

Sanofi (United States)

Chinese Academy of Sciences

Shanghai Institute of Organic Chemistry

Albert Einstein College of Medicine

Dimitry Ofengeim is an author at Harvard University specializing in medicine, neurology, and neuroscience.

ORCID

Top concepts

Publications per year

2006–2025

26

Publications

26

RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS

Yasushi Ito, Dimitry Ofengeim, Ayaz Najafov et al. · Science · 2016 · 591 citations · Full text

, , +17

Activation of Necroptosis in Multiple Sclerosis

Dimitry Ofengeim, Yasushi Ito, Ayaz Najafov et al. · Cell Reports · 2015 · 508 citations · Full text

TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging

Daichao Xu, Taijie Jin, Hong Zhu et al. · Cell · 2018 · 445 citations · Full text

, , +7

RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease

Dimitry Ofengeim, Sonia Mazzitelli, Yasushi Ito et al. · Proceedings of the National Academy of Sciences · 2017 · 366 citations · Full text

Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration

Sean K. Ryan, Matija Zelic, Yingnan Han et al. · Nature Neuroscience · 2022 · 309 citations · Full text

Rows per page

1–5 of 26